Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesiritide for Renal Function in TAH and LVAD Patients
NCT01836809Phase 4Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Apr 2013
- Primary completion
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of nesiritide in cardiorenal syndrome (CRS), chronic kidney disease (CKD), sponsored by Virginia Commonwealth University. Started Apr 2013; status: terminated.
02
Drugs
nesiritide
03
Conditions
cardiorenal syndrome (CRS)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01836809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01836809.